Breadcrumb
RI-MUHC researcher invited to provide expert testimony to the House of Commons regarding her project, the Montreal Antenatal Well-Being Study...
MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine
Honours and awards published August 2022 – July 2023